Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Matt Davidson
AddedFeb 15, 2024
UpdatedMay 31, 2026
Matt Davidson

Matt Davidson

Founder, Verrica Pharmaceuticals

CrunchbaseLinkedIn

Matt Davidson's Career

Verrica Pharmaceuticals
Verrica Pharmaceuticals

West Chester, PA, US

Founder
Azora Therapeutics
Azora Therapeutics

Los Angeles, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Matt Davidson's Career

Verrica Pharmaceuticals
Verrica Pharmaceuticals
Public$112.5M462013West Chester, PA, US
Founder

Recent news

The 2025 Startup Battlefield 200 is here — see who made the cutTechCrunch · 2025

Leadership at Verrica Pharmaceuticals

Paul ManningPaul ManningBoard Member
Ted WhiteTed WhiteCEO
Sean StalfortSean StalfortBoard Member
Mark PrygockiMark PrygockiBoard Member
Craig BallaronCraig BallaronBoard Member

Similar to Verrica Pharmaceuticals

VeraDermicsVeraDermicsSan Antonio, TX, USDrug Delivery, Therapeuticsest. 2019VeraDermicsSan Antonio, TX, US · est. 2019

VeraDermics: A dermatology firm offering pain-free, microneedle patch solutions for skin conditions.

Series B · $35.7M11
VeruVeruMiami, FL, USCancer Treatments, Pharmaceuticalsest. 2016VeruMiami, FL, US · est. 2016

Veru: An oncology biopharmaceutical firm innovating novel treatments for prostate and breast cancers.

Public · $133M375
Ivrea PharmaceuticalsIvrea PharmaceuticalsQuincy, MA, USMedication, Pharmaceuticalsest. 2005Ivrea PharmaceuticalsQuincy, MA, US · est. 2005

Ivrea Pharmaceuticals: Specializing in dermatology prescriptions for conditions like acne, serving the US.

Public · $5.1M5
SkinvisibleSkinvisibleLas Vegas, NV, USTopical Deliveryest. 1999SkinvisibleLas Vegas, NV, US · est. 1999

Skinvisible, Inc.: Innovating polymer-based topical delivery systems for pharmaceutical and skincare industries.

Public2
Azora Therapeutics
Azora Therapeutics
Pre-Seed$8.3M22017Los Angeles, CA, US
Co-Founder

Leadership at Azora Therapeutics

Julie SaikiJulie SaikiCo-Founder

Similar to Azora Therapeutics

AztherapiesAztherapiesBoston, MA, USTherapiesest. 2011AztherapiesBoston, MA, US · est. 2011

AZTherapies: A Boston-based life science firm innovating therapies for neurodegenerative diseases.

Series B · $99.8M38
Aristea TherapeuticsAristea TherapeuticsSan Diego, CA, USDrugsest. 2018Aristea TherapeuticsSan Diego, CA, US · est. 2018

Aristea Therapeutics: Developing novel drugs for autoimmune and inflammatory diseases.

Series B · $117.6M75
Forward TherapeuticsForward TherapeuticsPalm Beach Gardens, FL, USOral Therapiesest. 2022Forward TherapeuticsPalm Beach Gardens, FL, US · est. 2022

Forward Therapeutics: Innovating chronic inflammatory treatment through advanced oral immune therapies.

Series A · $50M2
Exalys TherapeuticsExalys TherapeuticsSan Diego, CA, USDrugs, Therapeuticsest. 2018Exalys TherapeuticsSan Diego, CA, US · est. 2018

Exalys Therapeutics develops novel anti-inflammatory drugs, targeting diseases with limited treatments.

Series A · $15M32

Matt Davidson's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · Kakao

People Similar to Matt Davidson

Dave StaskinDave StaskinFounder · UroCureJulien VidalJulien VidalCo-Founder · AZmedDavid ThompsonDavid ThompsonCo-Founder · Azure BiotechPhilipp BuschmannPhilipp BuschmannCo-Founder · AAZZURDon DavidsonDon DavidsonCo-Founder · Creative BioTherapeutics